Semaglutide Semaglutide is a clinician-guided GLP-1 medication that helps regulate appetite and support metabolic balance
Clinical trial data showed gallbladder issues in 1.4% of participants, and all cases involved people eating very low-fat diets
The unglamorous answer is a calorie intake at or slightly above maintenance, a high protein target, and eighteen months of real strength training
Retatrutide has shown promising diabetes management results in clinical trials, with significant improvements in blood sugar control and insulin sensitivity
Bottom line Retatrutide is still in clinical trials, with early data suggesting significant weight loss potential, while tirzepatide has FDA approval and proven efficacy and safety history
As far as peptides go, Koniver seemed to support Americas public-health agencies coming under new management